Loading…
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company trades wholesale and retail in pharmaceutical products sourced locally. Registered on 1 July 1995.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| 2,521 | 2,915 | 3,049 | 3,146 | 2,866 | 2,177 | 2,312 | -1.4% | |
| Total COGS | 2,183 | 2,517 | 2,604 | 2,692 | 2,461 | 1,938 | 2,075 | -0.8% |
| Gross Profit | 338 | 398 | 445 | 454 | 405 | 238 | 237 | -5.7% |
| Gross Margin | 13.4% | 13.6% | 14.6% | 14.4% | 14.1% | 11.0% | 10.3% | |
| 206 | 233 | 281 | 284 | 312 | 317 | 363 | +9.9% | |
| EBITDA | 132 | 165 | 164 | 170 | 93 | 79 | 125 | nmf |
| EBITDA Margin | 5.2% | 5.7% | 5.4% | 5.4% | 3.2% | 3.6% | 5.4% | |
| Total D&A | 5 | 8 | 4 | 4 | 4 | 5 | 14 | +17.8% |
| EBIT / Operating Income | 127 | 157 | 161 | 166 | 89 | 84 | 139 | nmf |
| 27 | 0 | 43 | 41 | 4 | 12 | 6 | -21.8% | |
| Profit Before Tax | 154 | 157 | 204 | 207 | 93 | 72 | 133 | nmf |
| Total Income Tax | 15 | 14 | 15 | 13 | 17 | 16 | 16 | +0.5% |
| Net Profit / (Loss) | 117 | 143 | 149 | 156 | 75 | 89 | 149 | nmf |
| Net Margin | 4.6% | 4.9% | 4.9% | 5.0% | 2.6% | 4.1% | 6.4% | |
| Other Comprehensive Income | 0 | 0 | 67 | 0 | 0 | 80 | 0 | +5.7% |
| Total Comprehensive Income | 117 | 143 | 216 | 156 | 75 | 9 | 149 | nmf |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →